EFTA00373935.pdf
PDF Source (No Download)
Extracted Text (OCR)
From: Lesley Groff <I
To: Joseph Thakuria
Cc: Rich Kahn <
Subject: Re: Jeffrey Epstein
Date: Sun, 02 Mar 2014 15:53:40 +0000
>
>
>
Hi Joe...I have passed along to Jeffrey.. thanks!
On Mar 1, 2014, at 2:41 PM, Joseph Thakuria
> wrote:
Hi Richard, my study is still awaiting irb approval at mgh. Once that goes through, there'll be a
consent form for Jeffrey to review and sign and then I can forward the invoice from Illumina for the
rapid turn-around-time whole genome.
Once we have his data and go through the analyses Illumina provides, I can discuss with him any
extra value from using additional tools for analyses.
The irb approval process will take 3-5 weeks in the best case scenario. As a physician, I could just
order it for him from Illumina but Jeffrey and I agreed the research route made the most sense. For
one, ordering a whole genome on a (presumably) healthy patient is not currently indicated. Doing this
as a patient (at least at mgh) would also entail creating a medical record of the encounter and the
results. Our plan is to keep this data private - at least until he's had a chance to review with me. So,
for this reason, we also agreed to go the "research study" route with his genome.
I've discussed doing Jeffrey's genome through my mgh study with george church and he's fine with it.
I'll coordinate getting JE's samples from the pgp and moving all of it, or a portion (aliquots of the dna
and cell lines) to the new study (again, after the mgh study is formally approved - that's the
bottleneck now).
Lesley, with Jeffrey not on the cc, please pass the info above on to him. Let me know if he has any
questions. I can clarify anything by email or phone.
Maybe there was a misunderstanding when I mentioned the 'rapid turnaround time' offering from
illumina? This just means illumina's role - the sequencing of the sample - is expedited. There is no
way, unfortunately, to expedite the MGH IRB process for approving human research studies. (A lot of
us wish there was!)
Joe Thakuria
Joseph V. Thakuria, MD, MMSc
Medical Genetics and Metabolism Attending Physician
Director, MGH Stickler Syndrome Program
Harvard Catalyst CRC Protocol Review Committee
Massachusetts General Hospital
185 Cambridge St., Rm. 2222
Boston, MA 02115
Office: (617) 726-1561
Fax: (617) 726-1566
Email: jthakuria@mgh.harvard.edu
EFTA00373935
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Dates
Email Addresses
Phone Numbers
Document Details
| Filename | EFTA00373935.pdf |
| File Size | 80.8 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 2,385 characters |
| Indexed | 2026-02-11T16:10:46.781573 |